📋About Viz.ai
Updated August 26, 2026Viz.ai is a healthcare AI company that develops AI-powered clinical decision support tools for detecting and triaging time-sensitive medical conditions. Founded in 2016 by Chris Mansi (a neurosurgeon) and David Golan, the company has FDA clearance for multiple AI algorithms and is used in over 1,800 hospitals.
Viz.ai's platform automatically analyzes medical images (CT scans, ECGs, ultrasounds) using AI algorithms to detect conditions like large vessel occlusion strokes, pulmonary embolisms, aortic dissections, and intracranial hemorrhages. When a critical finding is detected, the system instantly alerts the relevant specialist team — bypassing traditional communication chains that can delay life-saving treatment by hours. The platform has been shown to significantly reduce treatment times for stroke patients.
Viz.ai's clinical integration sets it apart from many healthcare AI companies — the system is embedded in hospital workflows, runs 24/7 on incoming scans, and takes autonomous action (alerting specialists) rather than waiting for human review. The company's expanding library of AI algorithms, growing hospital network, and demonstrated clinical impact make it one of the most commercially successful deployments of AI in acute healthcare.
🛠️Products & Tools (1)
Medical AI platform detecting time-sensitive conditions from imaging. Nearly 2,000 hospitals, 230 million lives covered. FDA-cleared tools for stroke, hemorrhage, pulmonary embolism, and more.
Keep track of the companies you’re watching
- Save the companies you want to follow
- Get ⚡ alerts when your saved companies change
- Every product they ship, cross-linked to 900+ AI tool profiles
- Today’s top AI Stories — the day’s most important AI news, free
Swipe for Recommended for you and My AI Tools
Your AI Hub — sample data. See desktop view example



